This could be huge … and disruptive

ACLU seems to have taken down the BRCA gene patent from Myriad Genetics.

This could actually change a chunk of the drug development business model. I am not sure if this is a good thing (the business model change), though I also didn’t think that one could patent what is effectively naturally generated prior art.

Patents are about reducing theory to practice, and then providing a temporary monopoly on the use of that reduction to practice. This is the basis for small startups to discover a specific gene, what it controls, what impacts it, ask for venture money, and then go and develop a drug.

That monopoly has been, from first glance, torn away.

The impact of this could be huge. We’ll see.

Viewed 13482 times by 3243 viewers


One thought on “This could be huge … and disruptive

Comments are closed.